Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

27.49CNY
29 Mar 2017
Change (% chg)

¥-0.65 (-2.31%)
Prev Close
¥28.14
Open
¥27.92
Day's High
¥27.92
Day's Low
¥26.94
Volume
34,461,430
Avg. Vol
9,346,558
52-wk High
¥28.90
52-wk Low
¥18.25

Latest Key Developments (Source: Significant Developments)

Shanghai Fosun Pharmaceutical Group to pay cash 3.5 yuan per 10 shares as FY 2016 div payment
4:05am EDT 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> :Says it plans to pay cash 3.5 yuan per 10 shares as FY 2016 div payment.  Full Article

Shanghai Fosun Pharmaceutical to issue up to 10 bln yuan debt financing tools
Tuesday, 28 Mar 2017 09:27am EDT 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS><2196.HK> : Says 2016 net profit up 14.1 percent y/y .Says it plans to issue up to 10 billion yuan ($1.45 billion) debt financing instruments.  Full Article

Shanghai Fosun Pharmaceutical Group issues first tranche corporate bonds worth 1.25 bln yuan
Wednesday, 15 Mar 2017 03:59am EDT 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> :Says it issued first tranche corporate bonds worth 1.25 billion yuan, with coupon rate 4.5 percent.  Full Article

Shanghai Fosun Pharma says reports on its bid for Germany's Stada inaccurate
Friday, 10 Mar 2017 05:37am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS><2196.HK> :Says media reports on its bid for Germany's Stada worth 3.6 billion euros ($3.82 billion) are inaccurate.  Full Article

Shanghai Fosun Pharmaceutical says no plans or arrangements in relation to bidding
Friday, 10 Mar 2017 05:30am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS> : Recently, there have been media reports on co's plan to join bidding for acquisition of Stada Arzneimittel AG .Company has no plans or arrangements in relation to bidding mentioned in media reports.  Full Article

Kite Pharma names Richard Wang CEO of Fosun Kite Biotechnology Co Ltd
Sunday, 5 Mar 2017 04:00pm EST 

Kite Pharma Inc : Richard L. Wang named chief executive officer of Fosun Kite Biotechnology Co, Ltd, a joint venture to lead development of axicabtagene ciloleucel and other engineered T-cell therapies for treatment of cancers in China .Richard wang named CEO of Fosun Kite Biotechnology Co Ltd.  Full Article

Shanghai Fosun Pharma's president increased H-shares holdings in the company
Thursday, 19 Jan 2017 05:00am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS><2196.HK> :Says President Wu Yifang has bought 16,000 H-share in the company on Jan 19 at average price of about HK$24.92 per share.  Full Article

Shanghai Fosun Pharma's controlling shareholder bought 154,000 H-shares on Jan 17
Wednesday, 18 Jan 2017 04:39am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS><2196.HK> :Says controlling shareholder has bought 154,000 H-shares in the company at about HK$24.48 per share on Jan 17.  Full Article

Shanghai Fosun Pharmaceutical Group unit to set up hospital management JV
Thursday, 12 Jan 2017 03:32am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>: Says its unit and a Huaian-based hospital to set up a JV for construction, management and operation of hospital .Says the unit will hold 60 percent stake in the JV.  Full Article

Shanghai Fosun Pharma gets approval to list unit Sisram Medical in Hong Kong
Friday, 23 Dec 2016 04:19am EST 

Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS><2196.HK> :Says it gets China securities regulator's approval to list unit Sisram Medical in Hong Kong.  Full Article

More From Around the Web